Correlation between clinical classification and genetic analysis of familial hypercholesterolemia in premature coronary artery disease in a cohort of Egyptian patients
Abstract Background Familial Hypercholesterolemia (FH) is a major risk factor for premature Coronary Artery Disease (CAD). Genetic testing is the gold standard for FH diagnosis. The purpose of this Observational Analytical Cross-sectional study was to estimate the proportion of genetically confirmed...
Saved in:
| Main Authors: | Rania A. Zahwo, Ziad N. Rezk, Tamer M. Elwasify, Amr M. Zaki, Hoda M. El Assi, Eman Ramadan, Abdallah Y. Habib, Wael A. Hassan, Ahmed Abdel-Raouf, Ameera Ragheb, Amin F. Shaker, Khaled E. Amer, Heba Sh. Kassem |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-06-01
|
| Series: | Human Genomics |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40246-025-00769-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
School-based universal screening for hypercholesterolemia in children
by: Chang-Hsien Yu, et al.
Published: (2022-07-01) -
Circulating microRNAs as biomarkers for ischemic heart disease: a systematic review and gene set enrichment analysis
by: Yasmine Alcibahy, et al.
Published: (2025-08-01) -
Hypertension and Hypercholesterolemia: is it Time for Anti-«Lipitensive» Therapy?
by: Z. D. Kobalava, et al.
Published: (2020-11-01) -
DIAGNOSIS AND TREATMENT OF PATIENTS WITH SEVERE HYPERCHOLESTEROLEMIA IN REAL OUTPATIENT PRACTICE (ACCORDING TO THE RECVASA REGISTRY)
by: A. I. Ershova, et al.
Published: (2015-09-01) -
Chitosan treatment abrogates hypercholesterolemia-induced erythrocyte’s arginase activation
by: Gamaleldin I. Harisa, et al.
Published: (2017-01-01)